John Fitzgerald, BSc(Hons) MBA
John is the Director of Strategic Research at the Western Australian Institute for Medical Research. He is responsible for both large strategic projects and a range of operational functions within the Institute.
Most recently, John has been integral to the funding and building of Western Australia’s two new state-of-the-art medical research facilities under construction at the QEII Medical Centre, Nedlands and the new Fiona Stanley Hospital campus at Murdoch. Prior to this he was instrumental in the building of the State’s first early stage clinical trial facility and the creation of its operating company Linear Clinical Research Ltd.
With nearly twenty years experience in research-based, for-profit and not-for-profit biomedical organisations, John has developed a broad experience base from his various roles, including Australasian Marketing Director for a multinational pharmaceutical company, Chief Operating Officer of a local biotechnology start-up and Executive Manager of Corporate Services in a WA Community Services organisation.
John is a Director of MiReven Pty Ltd and formerly a foundation Director of Linear Clinical Research Ltd. John holds a Master’s degree in Business Administration and an Honours Degree in Physiology, both from the University of Western Australia.
Samantha South, PhD MBA GAICD
Dr South is a Project Manager -Commercialisation managing Life Sciences related technology transfer at The University of Western Australia Office of Industry and Innovation and joined the MiReven Board of Directors in June 2011.
Dr Samantha South has over ten years experience in business development, technology project management and commercialisation in the life-sciences sector, which includes the assessment and valuation of new technologies, protection of intellectual property, and management of partner and stakeholder relationships at the level of university, enterprise and government.
Samantha was previously Efficacy Manager at TetraQ, a preclinical contract organisation providing appropriate commercial and regulatory compliant information for the pharmaceutical, biotechnology and complimentary medicine industries.
Samantha has a PhD in behavioural pharmacology and has held research appointments at Weill Medical College of Cornell University, The University of Queensland and The Garvan Institute. Samantha’s research management experience ranges from graduate student supervision and authoring original scientific publications to serving on grant review and scientific advisory panels and receiving commercially-relevant grants.